Medico Intercontinental Limite (BSE: MIL.BO) AI-Powered Stock Analysis
See how Medico Intercontinental Limite scores across key metrics like financial growth, valuation, and market position on the BSE, using AI-driven evaluation.
MIL.BO●BSE
Financial ServicesFinancial - Conglomerates
₹28.72
₹1.78(5.84%)
Indian Market opens in 5h 37m
Model Information
The AI Stock Analysis Model is provided for informational purposes only and should not be considered financial advice. We are continuously improving this model to increase accuracy and performance.Read our Full DisclaimerMedico Intercontinental Limite (BSE: MIL.BO) Stock Overall Grade
Medico Intercontinental Limite's grade for its BSE listing, based on a comprehensive AI analysis of financial metrics, growth potential, and market position.
Z
Grade Breakdown by Metric
See how each financial and market factor contributes to Medico Intercontinental Limite's overall BSE stock rating.
Forecast
BScore
68/100Financial Growth
CScore
40/100Fundamental Growth
C+Score
58/100Key Ratios
CScore
48/100Sector Comparison
AScore
85/100Industry Comparison
C+Score
50/100S&P 500 Benchmark
A+Score
98/100Analyst Consensus
C+Score
50/100Medico Intercontinental Limite (BSE: MIL.BO) AI-Powered Stock Analysis
On the BSE, MIL.BO demonstrates Good performance with an overall Forecast Score of 68/100 (B), reflecting high confidence in its potential. Financial Growth (40/100, C) and Fundamental Growth (58/100, C+) highlight its stability, while Key Ratios (48/100, C) and Sector Comparison (85/100, A) indicate solid positioning. Compared to broader benchmarks like the S&P 500 (98/100, A+), the BSE-listed stock shows competitive strength. Analyst Consensus (50/100, C+) suggests High divergence in outlook.(BSE: MIL.BO) Component Analysis Explained
Understand the key factors behind each Medico Intercontinental Limite (BSE: MIL.BO) stock grade, including financials, comparisons, and forecasts.